Clinical trialNCT05608681RecruitingPhase 1/PHASE2Interventional

A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).

SponsorEupraxia Pharmaceuticals Inc.Enrollment117Eosinophilic Esophagitis

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Mark Kowalski, MD PhD
Eupraxia Pharmaceuticals
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Campbelltown Private Hospital
Sydney, New South Wales, Australia
Vincent Ho, MD
Recruiting
Mater Hospital Brisbane
Brisbane, Queensland, Australia
Yoon-Kyo An
Recruiting
Princess Alexandra Hospital
Brisbane, Queensland, Australia
Gerald Holtmann, MD
Recruiting
Coastal Digestive Health
Maroochydore, Queensland, Australia
Hans Seltenreich
Recruiting
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Nam Nguyen, MD
Recruiting
Eastern Health Box Hill
Box Hill, Victoria, Australia
Sanjay Nandurkar, MD
Recruiting
Northern Hospital Epping
Epping, Victoria, Australia
Mayur Garg
Recruiting
the Alfred Hospital
Melbourne, Victoria, Australia
Rebecca Burgell
Recruiting
Royal Melbourne Hospital
Parkville, Victoria, Australia
Nicholas Hannah
Recruiting

Canada

University of Calgary
Calgary, Alberta, Canada
Milli Gupta
Recruiting
Uoa - South Edmonton Gastroenterology Research Clinic
Edmonton, Alberta, Canada
Jesse Siffledeen
Recruiting
G.I. Research Institute
Vancouver, British Columbia, Canada
Hin Hin Ko, MD
Recruiting
Mcgill University Health Center
Montreal, Quebec, Canada
Waqqas Afif, MD
Recruiting

Netherlands

Amsterdam Umc
Amsterdam, Netherlands
Active, not recruiting
Erasmus University Medical Center
Holland, Netherlands
Peter Siersema
Recruiting

New Zealand

Aotearoa Clinical Trials
Papatoetoe, Auckland, New Zealand
Tien Huey Lim
Recruiting
Waikato Hospital
Hamilton, New Zealand
Frank Weilert
Recruiting
Capital Coast and Hutt
Lower Hutt, New Zealand
Stephen Inns
Recruiting

Switzerland

Universitätsspital Zürich
Zurich, Switzerland
Christopher Schlag
Recruiting

United Kingdom

Norfolk and Norwich University Hospital
Norwich, Norfolk, United Kingdom
Ian Beales
Recruiting
Cardiff and Vale University Health Board-Wales
Cardiff, United Kingdom
Hasan N Haboubi
Recruiting
Royal Liverpool University Hospital
Liverpool, United Kingdom
Andrew Moore
Recruiting
St George'S University of London
London, United Kingdom
Jamal Hayat
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Mar 2023
Primary completion: 31 Dec 2026
Completion: 31 Dec 2026
Last update posted: 19 Mar 2026
Registered enrollment: 117
Registry id: NCT05608681

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.